Trials / Completed
CompletedNCT01145287
Impact of the Diagnosis of Celiac Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 760 (actual)
- Sponsor
- Tampere University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to assess the impact of the diagnosis of celiac disease on general health, healthcare resource utilization, quality of life and lifestyle. We hypothesize that diagnosis and subsequent dietary treatment may have positive impact on these variables.
Detailed description
All new members with biopsy-proven celiac disease joining the Finnish Celiac Society will be categorized in three groups according to symptoms and signs leading to the diagnosis as classical symptoms, extraintestinal symptoms and screen-detected, the latest being further divided to those presenting with symptoms and those who are totally asymptomatic. Several parameters assessing general health and well-being, quality of life and healthcare resource utilization are evaluated at baseline and after one and five years on trial. Quality of life is compared to that of non-celiac controls.
Conditions
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2010-06-16
- Last updated
- 2016-04-21
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01145287. Inclusion in this directory is not an endorsement.